Points to consider when doing a trial primarily involving the heart

被引：6

作者：

Allanore, Yannick ^{[1
,2
]}

Distler, Oliver ^{[3
]}

Walker, Ulrich A. ^{[4
]}

Khanna, Dinesh ^{[5
]}

Furst, Daniel E. ^{[6
]}

Meune, Christophe ^{[7
]}

机构：

[1] Paris Descartes Univ, Cochin Hosp, AP HP, Dept Rheumatol, Paris, France

[2] Paris Descartes Univ, Cochin Inst, AP HP, Paris, France

[3] Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland

[4] Univ Basel, Rheumatol Dept, Basel, Switzerland

[5] Univ Michigan, Dept Med, Scleroderma Program, Ann Arbor, MI 48109 USA

[6] Univ Calif Los Angeles, David Geffen Sch Med, Dept Rheumatol, Los Angeles, CA 90095 USA

[7] Cochin Hosp, AP HP, Dept Cardiol, Paris, France

来源：

RHEUMATOLOGY | 2017年 / 56卷

关键词：

systemic sclerosis; heart; heart failure; arrhythmia; pericarditis; cardiac fibrosis; myocarditis; TISSUE-DOPPLER-ECHOCARDIOGRAPHY; SYSTEMIC-SCLEROSIS; CARDIAC-ARRHYTHMIAS; MYOCARDIAL-PERFUSION; CONDUCTION DEFECTS; INVOLVEMENT; SCLERODERMA; DYSFUNCTION; PREVALENCE; MORTALITY;

D O I：

10.1093/rheumatology/kex198

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiac involvement contributes to the severity of SSc and should carefully be investigated and managed in SSc patients. Although it is commonly sub-clinical, once symptomatic it has a poor prognosis. Several complementary tools (circulating biomarkers, electrocardiography, echocardiography, scintigraphy or MRI) allow the assessment of all the various cardiac structures (endocardium, myocardium and pericardium) and heart function. Treatment remains empirical but cardiac trials in SSc can add data to the treatment of this complication.

引用

页码：V12 / V16

页数：5

共 34 条

[1]

Allanore Y, 2009, ANN RHEUM DIS, V69, P218

[2] Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies [J].

Allanore, Yannick ;

Meune, Christophe ;

Kahana, Andre .

CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (06) :697-702

[3]

Allanore Y, 2006, J RHEUMATOL, V33, P2464

[4] Cardiac Biomarkers in Systemic Sclerosis: Contribution of High-Sensitivity Cardiac Troponin in Addition to N-Terminal Pro-Brain Natriuretic Peptide [J].

Avouac, Jerome ;

Meune, Christophe ;

Chenevier-Gobeaux, Camille ;

Borderie, Didier ;

Lefevre, Guillaume ;

Kahan, Andre ;

Allanore, Yannick .

ARTHRITIS CARE & RESEARCH, 2015, 67 (07) :1022-1030

[5] Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis [J].

CandellRiera, J ;

ArmadansGil, L ;

Simeon, CP ;

CastellConesa, J ;

FonollosaPla, V ;

GarciaDelCastillo, H ;

VaqueRafart, J ;

Vilardell, M ;

SolerSoler, J .

ARTHRITIS AND RHEUMATISM, 1996, 39 (07) :1138-1145

[6]

Deuschle K, 2011, CLIN EXP RHEUMATOL, V29, pS53

[7] Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI) [J].

Di Cesare, Ernesto ;

Battisti, Sara ;

Di Sibio, Alessandra ;

Cipriani, Paola ;

Giacomelli, Roberto ;

Liakouli, Vasiliky ;

Ruscitti, Piero ;

Masciocchi, Carlo .

EUROPEAN JOURNAL OF RADIOLOGY, 2013, 82 (06) :E268-E273

[8] NONINVASIVE EVALUATION OF CARDIAC DYSRHYTHMIAS, AND THEIR RELATIONSHIP WITH MULTISYSTEMIC SYMPTOMS, IN PROGRESSIVE SYSTEMIC-SCLEROSIS PATIENTS [J].

FERRI, C ;

BERNINI, L ;

BONGIORNI, MG ;

LEVORATO, D ;

VIEGI, G ;

BRAVI, P ;

CONTINI, C ;

PASERO, G ;

BOMBARDIERI, S .

ARTHRITIS AND RHEUMATISM, 1985, 28 (11) :1259-1266

[9] Systemic sclerosis: Demographic, clinical, and serologic features and survival in 1,012 Italian patients [J].

Ferri, C ;

Valentini, G ;

Cozzi, F ;

Sebastiani, M ;

Michelassi, C ;

La Montagna, G ;

Bullo, A ;

Cazzato, M ;

Tirri, E ;

Storino, F ;

Giuggioli, D ;

Cuomo, G ;

Rosada, M ;

Bombardieri, S ;

Todesco, S ;

Tirri, G .

MEDICINE, 2002, 81 (02) :139-153

[10] CARDIAC AND SKELETAL-MUSCLE DISEASE IN SYSTEMIC-SCLEROSIS (SCLERODERMA) - A HIGH-RISK ASSOCIATION [J].

FOLLANSBEE, WP ;

ZERBE, TR ;

MEDSGER, TA .

AMERICAN HEART JOURNAL, 1993, 125 (01) :194-203

← 1 2 3 4 →